Login to Your Account

TransTech, Cephalon Partner Around Small-Molecule Targets

By Randall Osborne

Monday, June 24, 2002
Almost a year after netting its first collaboration with Novo Nordisk A/S, TransTech Pharma Inc. has chalked up its second - this one a multiyear deal with Cephalon Inc. to discover and develop small molecules for as many as three therapeutic targets. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription